Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Companion Animal Vaccines Market Growth 2022-2028

  • LP 4928722
  • 97 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Companion Animal Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Companion Animal Vaccines market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Companion Animal Vaccines market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Companion Animal Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Companion Animal Vaccines market, reaching US$ million by the year 2028. As for the Europe Companion Animal Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Companion Animal Vaccines players cover Bayer, Vetoquinol, Boehringer Ingelheim, and Ceva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Companion Animal Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Attenuated Live Vaccines

Conjugate Vaccines

Inactivated Vaccines

Subunit Vaccines

Toxoid Vaccines

DNA Vaccines

Recombinant Vaccines

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Canine

Avian

Feline

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Bayer

Vetoquinol

Boehringer Ingelheim

Ceva

Eli Lilly

Heska

Merck

Merial

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Companion Animal Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Companion Animal Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Companion Animal Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Companion Animal Vaccines Segment by Type

2.2.1 Attenuated Live Vaccines

2.2.2 Conjugate Vaccines

2.2.3 Inactivated Vaccines

2.2.4 Subunit Vaccines

2.2.5 Toxoid Vaccines

2.2.6 DNA Vaccines

2.2.7 Recombinant Vaccines

2.3 Companion Animal Vaccines Sales by Type

2.3.1 Global Companion Animal Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Companion Animal Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Companion Animal Vaccines Sale Price by Type (2017-2022)

2.4 Companion Animal Vaccines Segment by Application

2.4.1 Canine

2.4.2 Avian

2.4.3 Feline

2.5 Companion Animal Vaccines Sales by Application

2.5.1 Global Companion Animal Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Companion Animal Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Companion Animal Vaccines Sale Price by Application (2017-2022)

3 Global Companion Animal Vaccines by Company

3.1 Global Companion Animal Vaccines Breakdown Data by Company

3.1.1 Global Companion Animal Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Companion Animal Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Companion Animal Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Companion Animal Vaccines Revenue by Company (2020-2022)

3.2.2 Global Companion Animal Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Companion Animal Vaccines Sale Price by Company

3.4 Key Manufacturers Companion Animal Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Companion Animal Vaccines Product Location Distribution

3.4.2 Players Companion Animal Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Companion Animal Vaccines by Geographic Region

4.1 World Historic Companion Animal Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Companion Animal Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Companion Animal Vaccines Annual Revenue by Geographic Region

4.2 World Historic Companion Animal Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Companion Animal Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Companion Animal Vaccines Annual Revenue by Country/Region

4.3 Americas Companion Animal Vaccines Sales Growth

4.4 APAC Companion Animal Vaccines Sales Growth

4.5 Europe Companion Animal Vaccines Sales Growth

4.6 Middle East & Africa Companion Animal Vaccines Sales Growth

5 Americas

5.1 Americas Companion Animal Vaccines Sales by Country

5.1.1 Americas Companion Animal Vaccines Sales by Country (2017-2022)

5.1.2 Americas Companion Animal Vaccines Revenue by Country (2017-2022)

5.2 Americas Companion Animal Vaccines Sales by Type

5.3 Americas Companion Animal Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Companion Animal Vaccines Sales by Region

6.1.1 APAC Companion Animal Vaccines Sales by Region (2017-2022)

6.1.2 APAC Companion Animal Vaccines Revenue by Region (2017-2022)

6.2 APAC Companion Animal Vaccines Sales by Type

6.3 APAC Companion Animal Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Companion Animal Vaccines by Country

7.1.1 Europe Companion Animal Vaccines Sales by Country (2017-2022)

7.1.2 Europe Companion Animal Vaccines Revenue by Country (2017-2022)

7.2 Europe Companion Animal Vaccines Sales by Type

7.3 Europe Companion Animal Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Companion Animal Vaccines by Country

8.1.1 Middle East & Africa Companion Animal Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Companion Animal Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Companion Animal Vaccines Sales by Type

8.3 Middle East & Africa Companion Animal Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Companion Animal Vaccines

10.3 Manufacturing Process Analysis of Companion Animal Vaccines

10.4 Industry Chain Structure of Companion Animal Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Companion Animal Vaccines Distributors

11.3 Companion Animal Vaccines Customer

12 World Forecast Review for Companion Animal Vaccines by Geographic Region

12.1 Global Companion Animal Vaccines Market Size Forecast by Region

12.1.1 Global Companion Animal Vaccines Forecast by Region (2023-2028)

12.1.2 Global Companion Animal Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Companion Animal Vaccines Forecast by Type

12.7 Global Companion Animal Vaccines Forecast by Application

13 Key Players Analysis

13.1 Bayer

13.1.1 Bayer Company Information

13.1.2 Bayer Companion Animal Vaccines Product Offered

13.1.3 Bayer Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer Main Business Overview

13.1.5 Bayer Latest Developments

13.2 Vetoquinol

13.2.1 Vetoquinol Company Information

13.2.2 Vetoquinol Companion Animal Vaccines Product Offered

13.2.3 Vetoquinol Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Vetoquinol Main Business Overview

13.2.5 Vetoquinol Latest Developments

13.3 Boehringer Ingelheim

13.3.1 Boehringer Ingelheim Company Information

13.3.2 Boehringer Ingelheim Companion Animal Vaccines Product Offered

13.3.3 Boehringer Ingelheim Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Boehringer Ingelheim Main Business Overview

13.3.5 Boehringer Ingelheim Latest Developments

13.4 Ceva

13.4.1 Ceva Company Information

13.4.2 Ceva Companion Animal Vaccines Product Offered

13.4.3 Ceva Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ceva Main Business Overview

13.4.5 Ceva Latest Developments

13.5 Eli Lilly

13.5.1 Eli Lilly Company Information

13.5.2 Eli Lilly Companion Animal Vaccines Product Offered

13.5.3 Eli Lilly Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Eli Lilly Main Business Overview

13.5.5 Eli Lilly Latest Developments

13.6 Heska

13.6.1 Heska Company Information

13.6.2 Heska Companion Animal Vaccines Product Offered

13.6.3 Heska Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Heska Main Business Overview

13.6.5 Heska Latest Developments

13.7 Merck

13.7.1 Merck Company Information

13.7.2 Merck Companion Animal Vaccines Product Offered

13.7.3 Merck Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Merck Main Business Overview

13.7.5 Merck Latest Developments

13.8 Merial

13.8.1 Merial Company Information

13.8.2 Merial Companion Animal Vaccines Product Offered

13.8.3 Merial Companion Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Merial Main Business Overview

13.8.5 Merial Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Companion Animal Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Companion Animal Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Attenuated Live Vaccines

Table 4. Major Players of Conjugate Vaccines

Table 5. Major Players of Inactivated Vaccines

Table 6. Major Players of Subunit Vaccines

Table 7. Major Players of Toxoid Vaccines

Table 8. Major Players of DNA Vaccines

Table 9. Major Players of Recombinant Vaccines

Table 10. Global Companion Animal Vaccines Sales by Type (2017-2022) & (K Units)

Table 11. Global Companion Animal Vaccines Sales Market Share by Type (2017-2022)

Table 12. Global Companion Animal Vaccines Revenue by Type (2017-2022) & ($ million)

Table 13. Global Companion Animal Vaccines Revenue Market Share by Type (2017-2022)

Table 14. Global Companion Animal Vaccines Sale Price by Type (2017-2022) & (USD/Unit)

Table 15. Global Companion Animal Vaccines Sales by Application (2017-2022) & (K Units)

Table 16. Global Companion Animal Vaccines Sales Market Share by Application (2017-2022)

Table 17. Global Companion Animal Vaccines Revenue by Application (2017-2022)

Table 18. Global Companion Animal Vaccines Revenue Market Share by Application (2017-2022)

Table 19. Global Companion Animal Vaccines Sale Price by Application (2017-2022) & (USD/Unit)

Table 20. Global Companion Animal Vaccines Sales by Company (2020-2022) & (K Units)

Table 21. Global Companion Animal Vaccines Sales Market Share by Company (2020-2022)

Table 22. Global Companion Animal Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 23. Global Companion Animal Vaccines Revenue Market Share by Company (2020-2022)

Table 24. Global Companion Animal Vaccines Sale Price by Company (2020-2022) & (USD/Unit)

Table 25. Key Manufacturers Companion Animal Vaccines Producing Area Distribution and Sales Area

Table 26. Players Companion Animal Vaccines Products Offered

Table 27. Companion Animal Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 28. New Products and Potential Entrants

Table 29. Mergers & Acquisitions, Expansion

Table 30. Global Companion Animal Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 31. Global Companion Animal Vaccines Sales Market Share Geographic Region (2017-2022)

Table 32. Global Companion Animal Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 33. Global Companion Animal Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 34. Global Companion Animal Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 35. Global Companion Animal Vaccines Sales Market Share by Country/Region (2017-2022)

Table 36. Global Companion Animal Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 37. Global Companion Animal Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 38. Americas Companion Animal Vaccines Sales by Country (2017-2022) & (K Units)

Table 39. Americas Companion Animal Vaccines Sales Market Share by Country (2017-2022)

Table 40. Americas Companion Animal Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 41. Americas Companion Animal Vaccines Revenue Market Share by Country (2017-2022)

Table 42. Americas Companion Animal Vaccines Sales by Type (2017-2022) & (K Units)

Table 43. Americas Companion Animal Vaccines Sales Market Share by Type (2017-2022)

Table 44. Americas Companion Animal Vaccines Sales by Application (2017-2022) & (K Units)

Table 45. Americas Companion Animal Vaccines Sales Market Share by Application (2017-2022)

Table 46. APAC Companion Animal Vaccines Sales by Region (2017-2022) & (K Units)

Table 47. APAC Companion Animal Vaccines Sales Market Share by Region (2017-2022)

Table 48. APAC Companion Animal Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 49. APAC Companion Animal Vaccines Revenue Market Share by Region (2017-2022)

Table 50. APAC Companion Animal Vaccines Sales by Type (2017-2022) & (K Units)

Table 51. APAC Companion Animal Vaccines Sales Market Share by Type (2017-2022)

Table 52. APAC Companion Animal Vaccines Sales by Application (2017-2022) & (K Units)

Table 53. APAC Companion Animal Vaccines Sales Market Share by Application (2017-2022)

Table 54. Europe Companion Animal Vaccines Sales by Country (2017-2022) & (K Units)

Table 55. Europe Companion Animal Vaccines Sales Market Share by Country (2017-2022)

Table 56. Europe Companion Animal Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 57. Europe Companion Animal Vaccines Revenue Market Share by Country (2017-2022)

Table 58. Europe Companion Animal Vaccines Sales by Type (2017-2022) & (K Units)

Table 59. Europe Companion Animal Vaccines Sales Market Share by Type (2017-2022)

Table 60. Europe Companion Animal Vaccines Sales by Application (2017-2022) & (K Units)

Table 61. Europe Companion Animal Vaccines Sales Market Share by Application (2017-2022)

Table 62. Middle East & Africa Companion Animal Vaccines Sales by Country (2017-2022) & (K Units)

Table 63. Middle East & Africa Companion Animal Vaccines Sales Market Share by Country (2017-2022)

Table 64. Middle East & Africa Companion Animal Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 65. Middle East & Africa Companion Animal Vaccines Revenue Market Share by Country (2017-2022)

Table 66. Middle East & Africa Companion Animal Vaccines Sales by Type (2017-2022) & (K Units)

Table 67. Middle East & Africa Companion Animal Vaccines Sales Market Share by Type (2017-2022)

Table 68. Middle East & Africa Companion Animal Vaccines Sales by Application (2017-2022) & (K Units)

Table 69. Middle East & Africa Companion Animal Vaccines Sales Market Share by Application (2017-2022)

Table 70. Key Market Drivers & Growth Opportunities of Companion Animal Vaccines

Table 71. Key Market Challenges & Risks of Companion Animal Vaccines

Table 72. Key Industry Trends of Companion Animal Vaccines

Table 73. Companion Animal Vaccines Raw Material

Table 74. Key Suppliers of Raw Materials

Table 75. Companion Animal Vaccines Distributors List

Table 76. Companion Animal Vaccines Customer List

Table 77. Global Companion Animal Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 78. Global Companion Animal Vaccines Sales Market Forecast by Region

Table 79. Global Companion Animal Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Global Companion Animal Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 81. Americas Companion Animal Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Americas Companion Animal Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. APAC Companion Animal Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 84. APAC Companion Animal Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 85. Europe Companion Animal Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Europe Companion Animal Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Middle East & Africa Companion Animal Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 88. Middle East & Africa Companion Animal Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Global Companion Animal Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 90. Global Companion Animal Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 91. Global Companion Animal Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 92. Global Companion Animal Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 93. Global Companion Animal Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 94. Global Companion Animal Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 95. Global Companion Animal Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 96. Global Companion Animal Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 97. Bayer Basic Information, Companion Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 98. Bayer Companion Animal Vaccines Product Offered

Table 99. Bayer Companion Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Bayer Main Business

Table 101. Bayer Latest Developments

Table 102. Vetoquinol Basic Information, Companion Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 103. Vetoquinol Companion Animal Vaccines Product Offered

Table 104. Vetoquinol Companion Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Vetoquinol Main Business

Table 106. Vetoquinol Latest Developments

Table 107. Boehringer Ingelheim Basic Information, Companion Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 108. Boehringer Ingelheim Companion Animal Vaccines Product Offered

Table 109. Boehringer Ingelheim Companion Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Boehringer Ingelheim Main Business

Table 111. Boehringer Ingelheim Latest Developments

Table 112. Ceva Basic Information, Companion Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 113. Ceva Companion Animal Vaccines Product Offered

Table 114. Ceva Companion Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Ceva Main Business

Table 116. Ceva Latest Developments

Table 117. Eli Lilly Basic Information, Companion Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 118. Eli Lilly Companion Animal Vaccines Product Offered

Table 119. Eli Lilly Companion Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Eli Lilly Main Business

Table 121. Eli Lilly Latest Developments

Table 122. Heska Basic Information, Companion Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 123. Heska Companion Animal Vaccines Product Offered

Table 124. Heska Companion Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Heska Main Business

Table 126. Heska Latest Developments

Table 127. Merck Basic Information, Companion Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 128. Merck Companion Animal Vaccines Product Offered

Table 129. Merck Companion Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Merck Main Business

Table 131. Merck Latest Developments

Table 132. Merial Basic Information, Companion Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 133. Merial Companion Animal Vaccines Product Offered

Table 134. Merial Companion Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Merial Main Business

Table 136. Merial Latest Developments

List of Figures

Figure 1. Picture of Companion Animal Vaccines

Figure 2. Companion Animal Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Companion Animal Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Companion Animal Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Companion Animal Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Attenuated Live Vaccines

Figure 10. Product Picture of Conjugate Vaccines

Figure 11. Product Picture of Inactivated Vaccines

Figure 12. Product Picture of Subunit Vaccines

Figure 13. Product Picture of Toxoid Vaccines

Figure 14. Product Picture of DNA Vaccines

Figure 15. Product Picture of Recombinant Vaccines

Figure 16. Global Companion Animal Vaccines Sales Market Share by Type in 2021

Figure 17. Global Companion Animal Vaccines Revenue Market Share by Type (2017-2022)

Figure 18. Companion Animal Vaccines Consumed in Canine

Figure 19. Global Companion Animal Vaccines Market: Canine (2017-2022) & (K Units)

Figure 20. Companion Animal Vaccines Consumed in Avian

Figure 21. Global Companion Animal Vaccines Market: Avian (2017-2022) & (K Units)

Figure 22. Companion Animal Vaccines Consumed in Feline

Figure 23. Global Companion Animal Vaccines Market: Feline (2017-2022) & (K Units)

Figure 24. Global Companion Animal Vaccines Sales Market Share by Application (2017-2022)

Figure 25. Global Companion Animal Vaccines Revenue Market Share by Application in 2021

Figure 26. Companion Animal Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Companion Animal Vaccines Revenue Market Share by Company in 2021

Figure 28. Global Companion Animal Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Companion Animal Vaccines Revenue Market Share by Geographic Region in 2021

Figure 30. Global Companion Animal Vaccines Sales Market Share by Region (2017-2022)

Figure 31. Global Companion Animal Vaccines Revenue Market Share by Country/Region in 2021

Figure 32. Americas Companion Animal Vaccines Sales 2017-2022 (K Units)

Figure 33. Americas Companion Animal Vaccines Revenue 2017-2022 ($ Millions)

Figure 34. APAC Companion Animal Vaccines Sales 2017-2022 (K Units)

Figure 35. APAC Companion Animal Vaccines Revenue 2017-2022 ($ Millions)

Figure 36. Europe Companion Animal Vaccines Sales 2017-2022 (K Units)

Figure 37. Europe Companion Animal Vaccines Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Companion Animal Vaccines Sales 2017-2022 (K Units)

Figure 39. Middle East & Africa Companion Animal Vaccines Revenue 2017-2022 ($ Millions)

Figure 40. Americas Companion Animal Vaccines Sales Market Share by Country in 2021

Figure 41. Americas Companion Animal Vaccines Revenue Market Share by Country in 2021

Figure 42. United States Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Companion Animal Vaccines Sales Market Share by Region in 2021

Figure 47. APAC Companion Animal Vaccines Revenue Market Share by Regions in 2021

Figure 48. China Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Companion Animal Vaccines Sales Market Share by Country in 2021

Figure 55. Europe Companion Animal Vaccines Revenue Market Share by Country in 2021

Figure 56. Germany Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Companion Animal Vaccines Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Companion Animal Vaccines Revenue Market Share by Country in 2021

Figure 63. Egypt Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Companion Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Companion Animal Vaccines in 2021

Figure 69. Manufacturing Process Analysis of Companion Animal Vaccines

Figure 70. Industry Chain Structure of Companion Animal Vaccines

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390